UnitedHealth Group Inc has a consensus price target of $563.97, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Erste Group, B of A Securities, and Barclays on March 13, 2024, March 7, 2024, and March 6, 2024. With an average price target of $408.67 between Erste Group, B of A Securities, and Barclays, there's an implied -17.35% downside for UnitedHealth Group Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/13/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | — | Erste Group | Hans Engel | — | Downgrade | Buy → Hold | Get Alert |
03/07/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 36.52% | B of A Securities | Kevin Fischbeck | $675 → $675 | Maintains | Buy | Get Alert |
03/06/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 11.44% | Barclays | Andrew Mok | → $551 | Initiates | → Overweight | Get Alert |
02/29/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 20.54% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
02/08/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 22.36% | Stephens & Co. | Scott Fidel | → $605 | Reiterates | Overweight → Overweight | Get Alert |
01/19/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 19.53% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
01/17/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 23.37% | Oppenheimer | Michael Wiederhorn | → $610 | Reiterates | Outperform → Outperform | Get Alert |
01/17/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 17.51% | Piper Sandler | Jessica Tassan | $584 → $581 | Maintains | Overweight | Get Alert |
01/16/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 22.36% | Stephens & Co. | Scott Fidel | $615 → $605 | Maintains | Overweight | Get Alert |
01/16/2024 | UNH | Buy Now | UnitedHealth Group | $494.44 | 20.54% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
12/18/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | -2.92% | HSBC | Rajesh Kumar | $550 → $480 | Downgrade | Hold → Reduce | Get Alert |
12/13/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 18.32% | Stephens & Co. | Scott Fidel | → $585 | Reiterates | Overweight → Overweight | Get Alert |
11/30/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 23.37% | Truist Securities | David Macdonald | → $610 | Reiterates | Buy → Buy | Get Alert |
11/30/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 20.54% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
11/30/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 18.32% | Stephens & Co. | Scott Fidel | → $585 | Reiterates | Overweight → Overweight | Get Alert |
11/21/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 19.53% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
11/20/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 1.73% | Jefferies | David Windley | $565 → $503 | Maintains | Hold | Get Alert |
10/23/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 17.1% | Morgan Stanley | Ricky Goldwasser | $587 → $579 | Maintains | Overweight | Get Alert |
10/16/2023 | UNH | Buy Now | UnitedHealth Group | $494.44 | 20.54% | RBC Capital | Ben Hendrix | $572 → $596 | Maintains | Outperform | Get Alert |
The latest price target for UnitedHealth Group (NYSE: UNH) was reported by Erste Group on March 13, 2024. The analyst firm set a price target for $0.00 expecting UNH to fall to within 12 months (a possible -100.00% downside). 63 analyst firms have reported ratings in the last year.
The latest analyst rating for UnitedHealth Group (NYSE: UNH) was provided by Erste Group, and UnitedHealth Group downgraded their hold rating.
The last upgrade for UnitedHealth Group Inc happened on October 16, 2023 when UBS raised their price target to $640. UBS previously had a neutral for UnitedHealth Group Inc.
The last downgrade for UnitedHealth Group Inc happened on March 13, 2024 when Erste Group changed their price target from N/A to N/A for UnitedHealth Group Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UnitedHealth Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UnitedHealth Group was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
While ratings are subjective and will change, the latest UnitedHealth Group (UNH) rating was a downgraded with a price target of $0.00 to $0.00. The current price UnitedHealth Group (UNH) is trading at is $494.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.